Developer docs
API playgroundTry for free, no card

Search company profiles

No Barrier

Full company profile

uuid000f7i4

Namestring
No Barrier
Legal namestring
No Barrier AI, Inc.
Websiteurl
nobarrier.ai
Company typeenum
Private
Founded yearint
2023
Descriptiontext

No Barrier is a healthcare AI company that operates a HIPAA and SOC 2 Type II compliant real-time speech-to-speech medical interpretation platform, deployed across 150+ US healthcare sites in 12 states and used to bridge language gaps between clinicians and patients with limited English proficiency. The platform covers 295+ language access options with proprietary dialect detection (for example, distinguishing Cantonese from Mandarin or Puerto Rican from Mexican Spanish), auto-generates bilingual discharge notes, and falls back to human interpreters for complex medical discussions. Technology is built on healthcare-specific AI training over 15+ years of founder voice AI experience, hosted on AWS US-based infrastructure under a signed BAA, with AES-256 encryption and 7-day automatic PHI deletion.

No Barrier generates revenue through fixed-rate annual SaaS subscriptions sold to healthcare organizations, replacing the per-minute billing model of traditional remote interpretation services with predictable annual pricing that includes all languages and platform updates. Customers span Federally Qualified Health Centers, hospitals and health systems, outpatient and specialty clinics, and free and charitable clinics; documented outcomes include 50-70% cost reductions versus traditional interpretation, encounter-time compression from 22 to 12 minutes, and up to 30% clinician volume gains. The company pursues a hybrid go-to-market combining direct enterprise sales with a self-serve web app accessible on any connected device, supplemented by strategic channel access through the NACHC-ScaleHealth Accelerator 2026 cohort covering 1,400+ community health centers.

The company was founded in 2023 in San Francisco by three co-founders (Eyal Heldenberg as CEO, plus Moe and Tomer) and has raised $3.1 million in total funding, most recently a $2.7 million oversubscribed seed round in October 2025 led by A-Squared Ventures and Esplanade Ventures with Rock Health Capital and Fusion. Its 2026 clinical validation includes a peer-reviewed Mass General Brigham study published in NEJM Catalyst Innovations in Care Delivery testing the hybrid AI-human interpretation model in surgical settings.

Short descriptiontext

No Barrier is a San Francisco-based AI medical interpretation platform that provides HIPAA-compliant real-time speech-to-speech translation across 295+ languages for US healthcare providers serving limited-English-proficient patients, deployed at 150+ sites.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical interpretation services, AI healthcare interpreter, speech-to-speech translation, language access platform, clinical interpretation software
Industry1 code
1Speech Recognition, Dictation & Medical Transcription Platforms
CodeHLACAAAIPrimaryYes
NAICS code1 code
  • Translation and Interpretation Services541930
SIC code1 code
  • Services-Health Services8000
Product category
Healthcare Interpretation Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS Subscription - Fixed-Rate Platform
TypeSubscription Recurring
Description

Annual subscription model with fixed-rate pricing replacing traditional per-minute interpretation billing. Provides predictable annual pricing, eliminating per-minute charges, night-shift surcharges, and overtime fees. Includes all languages and platform updates.

nobarrier.ai
2Healthcare AI Interpretation Services
TypeSubscription Recurring
Description

Platform fees for access to AI medical interpretation technology across speech, phone, and video modalities. Revenue derived from healthcare organizations subscribing to the full interpretation suite.

nobarrier.ai
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details2 tiers
1Enterprise Healthcare Organizations
ModelSubscriptionBilling cadenceAnnual
Notes

Fixed annual subscription pricing with all languages included. No per-minute charges, no night-shift surcharges. Pilot available at zero upfront cost with full rollout following successful trial.

nobarrier.ai
2Full Interpretation Suite
ModelSubscriptionBilling cadenceAnnual
Notes

Includes real-time speech-to-speech AI interpretation, phone interpretation, and video interpretation across 295+ language access options. Human backup interpretation available when needed.

nobarrier.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

No Barrier sells an AI-powered medical interpretation platform that delivers real-time speech-to-speech, phone, and video interpretation across 295+ language access options for healthcare encounters. The HIPAA and SOC 2 Type II compliant platform replaces per-minute remote interpretation billing with fixed-rate annual subscriptions for healthcare organizations. Deployed across 150+ US healthcare sites, the platform reduces average encounter time from 22 to 12 minutes and targets roughly 50% cost reduction versus traditional language services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 63% cost reduction in interpretation services (Community Clinic NWA case study)
+7 more records
Product overview1 text field

No Barrier is a unified AI-powered healthcare interpretation platform consisting of a core AI Medical Interpretation Platform with three integrated service modules: AI Interpreting (real-time speech-to-speech), Phone Interpretation, and Video Interpretation. The platform provides clinical-grade interpretation across 295+ language access options at 50% lower cost than traditional language services. The core platform serves as the central hub enabling instant, HIPAA-compliant communication, while the interpretation modules deliver services across different modalities—speech (primary), phone, and video—all unified under one operational framework. The platform integrates into existing clinical workflows and EHR systems without requiring additional IT infrastructure.

Product and service3 records
1No Barrier Platform
CategoryHealthcare Interpretation Software
Description

AI-powered medical interpretation platform providing real-time speech-to-speech translation across 295+ language access options with HIPAA and SOC 2 Type II compliance, designed for ED, inpatient, outpatient, telehealth, and clinic workflows.

2AI Interpreting
CategorySpeech-to-Speech Interpretation
Description

Real-time AI-assisted interpreting module providing instant access to 295+ language options with speech recognition, visual supports for medical terms, and auto-generated bilingual discharge notes.

3Medical Interpretation Services
CategoryHealthcare Interpretation Services
Description

HIPAA-compliant on-demand medical interpretation covering ED, inpatient units, and clinics, supporting consent, diagnosis explanation, and care coordination with Section 1557/Title VI workflow alignment.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-12
Description

NACHC and ScaleHealth selected No Barrier into the inaugural NACHC Accelerator 2026 cohort. Nine-month program providing mentorship, business model refinement, and pilot planning support, culminating in fall 2026 showcase at HLTH USA. NACHC represents 1,400+ Community Health Center organizations serving 30 million patients.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-12
Description

Co-lead the NACHC Accelerator 2026 program alongside NACHC, providing innovation platform for scaling healthcare technologies in community health centers.

Strategic tierInfrastructureTypeTechnology or Integration
Description

No Barrier utilizes AWS secure US-based data centers for platform hosting. BAA signed with AWS for HIPAA-compliant infrastructure. Data encryption at rest and in transit using AES-256.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Market-leading remote interpretation provider serving the vast majority of US hospitals and health systems via phone, video, and on-site services. Recently launched its own AI interpretation offering (LanguageLine AI), making it the most direct incumbent competitor No Barrier must displace in enterprise contracts.

TypeBroad incumbent
Description

Major US provider of healthcare interpretation and translation services, offering phone and video interpretation across 200+ languages to hospitals, clinics, and health plans. Serves the same FQHC and hospital buyer base as No Barrier and is investing in AI-powered interpretation, making it a direct incumbent competitor.

TypeBroad incumbent
Description

Healthcare-focused interpretation provider offering video remote interpretation (VRI) and over-the-phone interpretation to hospitals and health systems nationwide. Competes for the same per-minute interpretation budget that No Barrier seeks to convert to fixed-rate AI pricing.

TypeBroad incumbent
Description

Healthcare interpretation platform (formerly part of UpHealth) offering video, audio, and in-person interpretation across more than 250 languages, with deep hospital system integrations. Directly comparable in target customer (US hospitals/clinics), modality mix, and language breadth.

TypeDirect peer
Description

AI-enabled medical interpretation platform providing real-time video, phone, and on-demand interpretation to hospitals and clinics across 250+ languages. Closely comparable product offering (AI + human hybrid interpretation) targeting the same healthcare buyer base.

TypeDirect peer
Description

Healthcare-focused video remote interpretation provider serving hospitals, clinics, and health systems with on-demand access to qualified medical interpreters. Direct overlap with No Barrier's hospital segment and video interpretation modality.

TypeDirect peer
Description

Interpretation platform offering remote interpretation management, scheduling, and a marketplace of interpreters for healthcare, legal, and business use cases. Targets the same healthcare interpretation buyer and has been adding AI/automated capabilities.

TypeEmerging player
Description

AI-powered speech interpretation platform for multilingual meetings and events, expanding into healthcare-adjacent use cases. Comparable AI speech-to-speech core technology and language breadth, though primarily focused on conferencing rather than clinical workflows.

TypeEmerging player
Description

AI translation company offering high-quality written and spoken translation across 30+ languages with a strong enterprise presence. Although primarily a written translation provider, its speech capabilities and enterprise AI translation stack represent a competitive threat if it expands into healthcare interpretation.

TypeOthers
Description

Hyperscaler healthcare AI services offering clinical speech recognition and documentation, including AWS HealthScribe and Azure Health AI services. No Barrier already relies on AWS infrastructure; these platforms represent both an enabling dependency and a competitive threat as hyperscalers add healthcare-specialized speech and translation capabilities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

No Barrier

Healthcare Interpretation Softwarenobarrier.ai

No Barrier is a San Francisco-based AI medical interpretation platform that provides HIPAA-compliant real-time speech-to-speech translation across 295+ languages for US healthcare providers serving limited-English-proficient patients, deployed at 150+ sites.

What No Barrier does

No Barrier is a healthcare AI company that operates a HIPAA and SOC 2 Type II compliant real-time speech-to-speech medical interpretation platform, deployed across 150+ US healthcare sites in 12 states and used to bridge language gaps between clinicians and patients with limited English proficiency. The platform covers 295+ language access options with proprietary dialect detection (for example, distinguishing Cantonese from Mandarin or Puerto Rican from Mexican Spanish), auto-generates bilingual discharge notes, and falls back to human interpreters for complex medical discussions. Technology is built on healthcare-specific AI training over 15+ years of founder voice AI experience, hosted on AWS US-based infrastructure under a signed BAA, with AES-256 encryption and 7-day automatic PHI deletion.

No Barrier generates revenue through fixed-rate annual SaaS subscriptions sold to healthcare organizations, replacing the per-minute billing model of traditional remote interpretation services with predictable annual pricing that includes all languages and platform updates. Customers span Federally Qualified Health Centers, hospitals and health systems, outpatient and specialty clinics, and free and charitable clinics; documented outcomes include 50-70% cost reductions versus traditional interpretation, encounter-time compression from 22 to 12 minutes, and up to 30% clinician volume gains. The company pursues a hybrid go-to-market combining direct enterprise sales with a self-serve web app accessible on any connected device, supplemented by strategic channel access through the NACHC-ScaleHealth Accelerator 2026 cohort covering 1,400+ community health centers.

The company was founded in 2023 in San Francisco by three co-founders (Eyal Heldenberg as CEO, plus Moe and Tomer) and has raised $3.1 million in total funding, most recently a $2.7 million oversubscribed seed round in October 2025 led by A-Squared Ventures and Esplanade Ventures with Rock Health Capital and Fusion. Its 2026 clinical validation includes a peer-reviewed Mass General Brigham study published in NEJM Catalyst Innovations in Care Delivery testing the hybrid AI-human interpretation model in surgical settings.

No Barrier firmographics

Firmographics
Name
No Barrier
Legal name
No Barrier AI, Inc.
Website
https://nobarrier.ai
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
1–10 employees
Short description
No Barrier is a San Francisco-based AI medical interpretation platform that provides HIPAA-compliant real-time speech-to-speech translation across 295+ languages for US healthcare providers serving limited-English-proficient patients, deployed at 150+ sites.
Ownership category
akta.pro rank

No Barrier industry classification

Industry
Product category
Healthcare Interpretation Software
NAICS
Translation and Interpretation Services (541930)
SIC
Services-Health Services (8000)
akta.pro primary industry
Speech Recognition, Dictation & Medical Transcription Platforms (HLACAAAI)

Keywords

  • Medical interpretation services
  • AI healthcare interpreter
  • Speech-to-speech translation
  • Language access platform
  • Clinical interpretation software

Where No Barrier is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

No Barrier business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. SaaS Subscription - Fixed-Rate Platform: Annual subscription model with fixed-rate pricing replacing traditional per-minute interpretation billing. Provides predictable annual pricing, eliminating per-minute charges, night-shift surcharges, and overtime fees. Includes all languages and platform updates.
  2. Healthcare AI Interpretation Services: Platform fees for access to AI medical interpretation technology across speech, phone, and video modalities. Revenue derived from healthcare organizations subscribing to the full interpretation suite.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise Healthcare Organizations
SubscriptionAnnualFull Interpretation Suite

Go-to-market motion2 records

Distribution channels3 records

Marketing channels9 records

No Barrier product offering

Product offering

Core offering

No Barrier sells an AI-powered medical interpretation platform that delivers real-time speech-to-speech, phone, and video interpretation across 295+ language access options for healthcare encounters. The HIPAA and SOC 2 Type II compliant platform replaces per-minute remote interpretation billing with fixed-rate annual subscriptions for healthcare organizations. Deployed across 150+ US healthcare sites, the platform reduces average encounter time from 22 to 12 minutes and targets roughly 50% cost reduction versus traditional language services.

Product overview

No Barrier is a unified AI-powered healthcare interpretation platform consisting of a core AI Medical Interpretation Platform with three integrated service modules: AI Interpreting (real-time speech-to-speech), Phone Interpretation, and Video Interpretation. The platform provides clinical-grade interpretation across 295+ language access options at 50% lower cost than traditional language services. The core platform serves as the central hub enabling instant, HIPAA-compliant communication, while the interpretation modules deliver services across different modalities—speech (primary), phone, and video—all unified under one operational framework. The platform integrates into existing clinical workflows and EHR systems without requiring additional IT infrastructure.

Differentiator

Problem solved

Functional benefit

Products and services

  • No Barrier Platform AI-powered medical interpretation platform providing real-time speech-to-speech translation across 295+ language access options with HIPAA and SOC 2 Type II compliance, designed for ED, inpatient, outpatient, telehealth, and clinic workflows.
  • AI Interpreting Real-time AI-assisted interpreting module providing instant access to 295+ language options with speech recognition, visual supports for medical terms, and auto-generated bilingual discharge notes.
  • Medical Interpretation Services HIPAA-compliant on-demand medical interpretation covering ED, inpatient units, and clinics, supporting consent, diagnosis explanation, and care coordination with Section 1557/Title VI workflow alignment.

Quantifiable outcome

  • 63% cost reduction in interpretation services (Community Clinic NWA case study)
  • +7 more outcomes

Companies that use No Barrier

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles3 records

No Barrier technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature7 records

No Barrier partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and infrastructure.

  • National Association of Community Health Centers (NACHC)coreStrategic or Co-development Partner · 12 March 2026NACHC and ScaleHealth selected No Barrier into the inaugural NACHC Accelerator 2026 cohort. Nine-month program providing mentorship, business model refinement, and pilot planning support, culminating in fall 2026 showcase at HLTH USA. NACHC represents 1,400+ Community Health Center organizations serving 30 million patients.
  • ScaleHealthcoreStrategic or Co-development Partner · 12 March 2026Co-lead the NACHC Accelerator 2026 program alongside NACHC, providing innovation platform for scaling healthcare technologies in community health centers.
  • AWS (Amazon Web Services)infrastructureTechnology or IntegrationNo Barrier utilizes AWS secure US-based data centers for platform hosting. BAA signed with AWS for HIPAA-compliant infrastructure. Data encryption at rest and in transit using AES-256.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

No Barrier competitors and assessment

Company assessment

Broad incumbents

  • LanguageLine Solutions: Market-leading remote interpretation provider serving the vast majority of US hospitals and health systems via phone, video, and on-site services. Recently launched its own AI interpretation offering (LanguageLine AI), making it the most direct incumbent competitor No Barrier must displace in enterprise contracts.
  • CyraCom: Major US provider of healthcare interpretation and translation services, offering phone and video interpretation across 200+ languages to hospitals, clinics, and health plans. Serves the same FQHC and hospital buyer base as No Barrier and is investing in AI-powered interpretation, making it a direct incumbent competitor.
  • Stratus Video (Language Access Network): Healthcare-focused interpretation provider offering video remote interpretation (VRI) and over-the-phone interpretation to hospitals and health systems nationwide. Competes for the same per-minute interpretation budget that No Barrier seeks to convert to fixed-rate AI pricing.
  • Martti (UpHealth): Healthcare interpretation platform (formerly part of UpHealth) offering video, audio, and in-person interpretation across more than 250 languages, with deep hospital system integrations. Directly comparable in target customer (US hospitals/clinics), modality mix, and language breadth.

Direct peers

  • Voyce Global: AI-enabled medical interpretation platform providing real-time video, phone, and on-demand interpretation to hospitals and clinics across 250+ languages. Closely comparable product offering (AI + human hybrid interpretation) targeting the same healthcare buyer base.
  • InDemand Interpreting: Healthcare-focused video remote interpretation provider serving hospitals, clinics, and health systems with on-demand access to qualified medical interpreters. Direct overlap with No Barrier's hospital segment and video interpretation modality.
  • Boostlingo: Interpretation platform offering remote interpretation management, scheduling, and a marketplace of interpreters for healthcare, legal, and business use cases. Targets the same healthcare interpretation buyer and has been adding AI/automated capabilities.

Emerging players

  • KUDO: AI-powered speech interpretation platform for multilingual meetings and events, expanding into healthcare-adjacent use cases. Comparable AI speech-to-speech core technology and language breadth, though primarily focused on conferencing rather than clinical workflows.
  • DeepL: AI translation company offering high-quality written and spoken translation across 30+ languages with a strong enterprise presence. Although primarily a written translation provider, its speech capabilities and enterprise AI translation stack represent a competitive threat if it expands into healthcare interpretation.

Others

  • AWS HealthScribe / Azure Health AI: Hyperscaler healthcare AI services offering clinical speech recognition and documentation, including AWS HealthScribe and Azure Health AI services. No Barrier already relies on AWS infrastructure; these platforms represent both an enabling dependency and a competitive threat as hyperscalers add healthcare-specialized speech and translation capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

No Barrier social profiles

Digital presence

No Barrier compliance and trust

Trust signal

Compliance3 records

No Barrier financial estimates

Financial estimate

Revenue estimate

Valuation estimate

No Barrier leadership team

Management profile

Number of profiles

Profiles2 records

No Barrier funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

No Barrier M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about No Barrier

What does No Barrier do?

No Barrier sells an AI-powered medical interpretation platform that delivers real-time speech-to-speech, phone, and video interpretation across 295+ language access options for healthcare encounters. The HIPAA and SOC 2 Type II compliant platform replaces per-minute remote interpretation billing with fixed-rate annual subscriptions for healthcare organizations. Deployed across 150+ US healthcare sites, the platform reduces average encounter time from 22 to 12 minutes and targets roughly 50% cost reduction versus traditional language services.

Is No Barrier a public or private company?

No Barrier is a private company. It is classified as venture growth investor backed and is currently operating.

When was No Barrier founded?

No Barrier was founded in 2023. It employs 1 to 10 people.

Where is No Barrier based?

No Barrier is headquartered in San Francisco, United States, in the North America region.

How does No Barrier make money?

Two revenue lines are on record. SaaS Subscription - Fixed-Rate Platform is the primary driver. The others are healthcare AI Interpretation Services.

Who are No Barrier's main competitors?

Broad incumbents on record are LanguageLine Solutions, CyraCom, Stratus Video (Language Access Network) and Martti (UpHealth). Direct peers are Voyce Global, InDemand Interpreting and Boostlingo. Emerging players are KUDO and DeepL. AWS HealthScribe / Azure Health AI is listed as an others.

Does No Barrier have an API?

No public API is recorded for No Barrier.

What industry is No Barrier in?

No Barrier's product category is Healthcare Interpretation Software. Its primary akta.pro industry code is HLACAAAI, Speech Recognition, Dictation & Medical Transcription Platforms. Its NAICS code is 541930 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0No Barrier: Interview With Co-Founder & CEO Eyal Heldenberg About The Medical Interpretation PlatformEyal Heldenberg, co-founder and CEO of No Barrier, discussed the company's HIPAA-compliant AI medical interpretation platform in an interview. The platform, launched in 2023, has raised $2.7 million in seed funding and works with over a dozen health organizations. Heldenberg cited a $8-9 billion total addressable market for medical oral interpretation.Digital JournalOvercoming the healthcare language barrier with AIA Mass General Brigham study of 23 Spanish-speaking surgical patients found they preferred flexible interpretation options, with AI valued for instant privacy and remote video for sensitive conversations. The findings, published in the New England Journal of Medicine, suggest a hybrid approach improves engagement and outcomes.HIT ConsultantNEJM Catalyst Study Validates No Barrier’s Hybrid AI-Human Model for High-Stakes Surgical CommunicationA study conducted at Mass General Brigham and published in NEJM Catalyst tested No Barrier's AI-powered medical interpretation platform against Remote Video Interpretation (RVI) among 23 Spanish-speaking surgical patients at Brigham and Women's Hospital. The research found that RVI was preferred for emotionally sensitive or high-stakes surgical conversations, while No Barrier's AI was valued for its immediacy and privacy, with patients expressing that a hybrid combination approach would be ideal. The findings support No Barrier's "AI-first" strategy combined with human expertise and suggest that the future of medical language access requires a hybrid infrastructure rather than a single interpretation method.HcinnovationgroupSix Startups Join Community Health Center Tech AcceleratorThe National Association of Community Health Centers (NACHC) and ScaleHealth announced the inaugural NACHC Accelerator 2026 cohort, selecting six startups from a competitive applicant pool to address operational and clinical challenges facing community health centers. The six selected companies—Cair Health, Claris Healthcare, Delfina Care, Era Supports, Luro Health, and No Barrier—specialize in AI and technology solutions spanning revenue cycle automation, remote patient care, maternal health, behavioral health, obesity care, and medical interpretation. Over nine months, the cohort will receive mentorship, business model refinement, and pilot planning support, culminating in a fall 2026 showcase at HLTH USA.Healthcare BrewStartup No Barrier is using AI to improve medical translationTech startup No Barrier has closed a $2.7 million seed funding round on November 17, led by venture capital firms A-Squared Ventures, Esplanade Ventures, Rock Health Capital, and Fusion, to advance its AI-powered medical translation platform. The HIPAA-compliant platform, founded by CEO Eyal Heldenberg, is currently deployed at more than 100 healthcare sites across 12 states and provides real-time speech-to-speech translation in over 40 languages including Spanish, Mandarin, and Arabic. The company aims to address language barriers affecting 26 million US residents with limited English proficiency in healthcare settings, targeting broader adoption and scalability over the next three to four years.SlatorSpatial Audio, IMDb Honors Dubs, Kindle AI Translations, Startup RoundsThis Slator podcast episode summarizes recent language industry news, covering Coursera's strategy shift under its new CEO toward AI translation and dubbing to address slowing growth, and Amazon's rollout of AI-translated Kindle eBooks promising 72-hour turnaround times despite questions about author adoption. In M&A and funding activity, Cisco announced the acquisition of EZ Dubs to strengthen WebEx's real-time speech translation, while healthcare AI startup No Barrier raised USD 2.7m and audio AI firm AudioShake raised USD 14m. Additional topics include OneMeta's revenue growth despite limited marketing, a landmark UK NHS framework agreement for language services, research on spatial audio improving AI live speech translation, and interpreting business performance at Teleperformance and AMN Healthcare.SlatorAI Interpreting Startup No Barrier Raises USD 2.7M to Scale HIPAA-Compliant PlatformHealthcare AI startup No Barrier announced on November 18, 2025, that it successfully closed a USD 2.7 million seed round in October 2025, led by A Squared Ventures and Esplanade Ventures with additional backing from Rock Health and Fusion, bringing total funding to date to USD 3.1 million. The capital will be used to expand No Barrier's AI language technology platform across the entire patient journey and points of care, with the platform already deployed at over 100 sites in 12 US states. The funding arrives as US policy increases pressure on healthcare institutions managing costs for patients with limited English proficiency, with No Barrier positioning its HIPAA-compliant real-time interpreting technology as a solution to replace traditional interpreter wait times averaging 30-45 minutes in emergency rooms.NobarrierNo Barrier Raises $2.7M to Remove Language Barriers in HealthcareNo Barrier, a healthcare AI interpretation company, has raised a $2.7 million oversubscribed seed round led by A Squared Ventures and Esplanade Ventures, with participation from Rock Health and Fusion. The funding will accelerate expansion of their platform that integrates into clinical workflows to provide real-time interpretation across 40+ languages, currently deployed across 100+ sites in 12 US states. The company was founded by three individuals with 15 years of voice AI experience who pivoted to healthcare in 2023 after identifying that 25.7 million people in the United States have limited English proficiency and that existing interpreter services average only 75% accuracy while being financially unsustainable for health systems.The SaaS NewsNo Barrier Raises $2.7 Million in Seed RoundNo Barrier, a San Francisco-based AI-powered medical interpretation platform, has raised $2.7 million in seed funding led by A Squared Ventures and Esplanade Ventures, with additional participation from Rock Health and Fusion. The funding will be used to accelerate expansion across clinical communication touchpoints, from patient check-in through diagnosis and treatment planning. The platform, which provides real-time medical interpretation in over 40 languages with zero wait time, is currently deployed across more than 100 sites in 12 states.Pulse 2.0No Barrier: $2.7 Million Raised To Expand Real-Time Medical Interpretation PlatformNo Barrier raised $2.7 million in a seed round led by A-Squared Ventures, Esplanade Ventures, Rock Health Capital, and Fusion. The funding will expand its real-time medical interpretation platform across healthcare settings. The company has deployed its technology at over 100 sites in 12 states, reducing interpretation costs by up to 70 percent.